| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02355535 | Breast Cancer|Lymphoma|Gastrointestinal Cancers|Genitourinary Cancers|Gynecologic Cancers|Head and Neck Cancers|Melanoma|Thoracic Cancers|Solid Tumors|Lymphomas | Drug: PAC-1 | Vanquish Oncology, Inc.|University of Illinois at Chicago | Phase 1 | 2015-02-01 | 2016-05-01 |
| NCT02355756 | Healthy Volunteers | Drug: Maxadilan|Drug: Placebo | Universitaire Ziekenhuizen Leuven | Early Phase 1 | 2015-01-01 | 2015-07-09 |
| NCT01454778 | Peripheral Vascular Disease | Drug: Paclitaxel | Patrick Kelly|Sanford Health | | 2011-04-01 | 2016-04-15 |
| NCT02530762 | Signs and Symptoms, Digestive | Other: Novel Fiber|Other: Positive Fiber control|Other: Negative Control | Cargill | | 2014-09-01 | 2015-08-20 |
| NCT00944996 | Major Depression | Drug: SSRI; SNRI; TCA | Tirat Carmel Mental Health Center|University of Michigan|Ariel University|The Nazareth Hospital, Israel | | 2009-06-01 | 2012-07-25 |
| NCT02532985 | Signs and Symptoms, Digestive | Other: Negative Control|Other: Positive Fiber Control|Other: Novel Fiber|Other: Novel Fiber|Other: Novel Fiber | Cargill | | 2014-10-01 | 2015-08-24 |
| NCT02100462 | Hypertension | Drug: Chlorthalidone 12.5 mg|Drug: Hydrochlorothiazide 25 mg|Drug: Aspirin 81 mg | Creighton University|Dialysis Clinic, Inc. | Phase 4 | 2014-03-01 | 2015-12-10 |
| NCT01865136 | Pregnancy | Other: Medical Post Abortion Care | Karolinska Institutet|Kenya Medical Research Institute|University of Nairobi | Phase 4 | 2013-09-01 | 2016-08-30 |
| NCT00106587 | Coronary Restenosis | Device: paclitaxel coated balloon catheter (device with drug) | University Hospital, Saarland | Phase 1|Phase 2 | 2003-12-01 | 2005-11-09 |
| NCT00075686 | Pancreatic Cancer | Biological: cetuximab|Drug: gemcitabine hydrochloride | Southwest Oncology Group|National Cancer Institute (NCI)|Cancer and Leukemia Group B|NCIC Clinical Trials Group | Phase 3 | 2004-01-01 | 2015-11-16 |
